There is little time left for Haleon plc ADR (HLN) to reach its 1-year target estimate. How soon will it surpass it?

Haleon plc ADR (NYSE:HLN) shares traded 1.38% higher at $8.07 on Wall Street last session.

In accordance with the data, 15 analysts cover Haleon plc ADR (NYSE:HLN). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.23 and a low of $6.82, we find $8.87. Given the previous closing price of $7.96, this indicates a potential upside of 11.43 percent. HLN stock price is now -1.55% away from the 50-day moving average and -2.73% away from the 200-day moving average. The market capitalization of the company currently stands at $37.26B.

It has been rated a hold by 6 analysts and a buy by 6. Brokers who have rated the stock have averaged $8.63 as their price target over the next twelve months.

With the price target of $9, Morgan Stanley recently initiated with Overweight rating for Haleon plc ADR (NYSE: HLN).

A total of 0.00% of the company’s stock is owned by insiders.

Haleon plc ADR (NYSE: HLN) opened at $7.96 on Friday. During the past 12 months, Haleon plc ADR has had a low of $6.07 and a high of $9.05. As of last week, the company has a debt-to-equity ratio of 0.60, a current ratio of 0.84, and a quick ratio of 0.54. The fifty day moving average price for HLN is $8.19 and a two-hundred day moving average price translates $8.30 for the stock.

The latest earnings results from Haleon plc ADR (NYSE: HLN) was released for Sep, 2023.

Haleon plc ADR(HLN) Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Related Posts